From Rs 5.82 to Rs 31.96 per share in 294 days: Pharma penny stock hit 5 per cent upper circuit on March 24 From Rs 5.82 to Rs 31.96 per share in 294 days: Pharma penny stock hit 5 per cent upper circuit on March 24 The stock gave multibagger returns of 449 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence / Monday, March 24, 2025 0 498 Article rating: 3.6 The stock gave multibagger returns of 449 per cent from its 52-week low of Rs 5.82 per share. Read more
Pharma Giant Expands with Strategic Acquisition in Singapore Pharma Giant Expands with Strategic Acquisition in Singapore The company has a strong presence in regulated markets such as the United States and Europe and is a leading producer of niche generic formulations. DSIJ Intelligence / Thursday, March 20, 2025 0 162 Article rating: 4.0 The company has been actively expanding its product pipeline, with over 70 commercialized products and a healthy pipeline of 100+ approved products. Read more
Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19 Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19 The stock gave multibagger returns of 160 per cent in just 1 year whereas BSE Sensex Index is up by 5 per cent. DSIJ Intelligence / Wednesday, March 19, 2025 0 889 Article rating: 3.6 The stock’s 52-week high is Rs 1,678.60 per share while its 52-week low is Rs 489.20 per share. Read more
Pharma Penny Stock Under Rs 50 in Green After Signing an MoU with Indian Navy (INS Kalinga) Pharma Penny Stock Under Rs 50 in Green After Signing an MoU with Indian Navy (INS Kalinga) The company has a market cap of over Rs 1,200 crore and has delivered good profit growth of 25 per cent CAGR over the last 5 years. DSIJ Intelligence / Thursday, March 13, 2025 0 391 Article rating: 3.4 From Rs 34.51 per share (52-week low) to Rs 38.29 per share, the stock is up by 11 per cent. Read more
Strategic Acquisition: Major MedTech Expansion by Indian Pharma Giant Strategic Acquisition: Major MedTech Expansion by Indian Pharma Giant Zydus Lifesciences Limited has announced its strategic decision to acquire a controlling stake in Amplitude Surgical SA, a France-based company listed on Euronext Paris. DSIJ Intelligence / Wednesday, March 12, 2025 0 238 Article rating: 3.3 Zydus Lifesciences Limited, a prominent player in the Indian pharmaceutical sector, is currently trading at a stock price of Rs 900 with a market capitalization of over Rs 90,000 crores. Read more